Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Indiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Indiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Indiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mark Kaehr (NPI 1427361450)

Field	Value
Entity Type	Individual
Organization	Mark Kaehr
Address	12794 Hamilton Crossing Blvd
City	Carmel
State	IN
ZIP	46032
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 19, 2010

Payer Source	Total Paid
Medicare	$2.7M
Medicaid	$0

Key Findings

MARK KAEHR is operating as a retina-focused ophthalmology practice whose Medicare revenue is overwhelmingly driven by intravitreal biologic therapy and retina procedures: J0178 (aflibercept) generated $1.6M in revenue and represents 60.2% of his Medicare revenue, J2777 (faricimab) generated $579.4K (21.4%), and 67028 (intravitreal injection as a separate procedure) generated $150.8K (5.6%). These three codes alone account for the precomputed top-3 share of 87.2% of total Medicare revenue, indicating the practice is built around recurring injection-based care for retinal disease rather than broad multispecialty outpatient services.

The provider’s Medicare revenue scale is $2.7M while Total Medicaid revenue is none (no Medicaid billing on file), making this effectively a single-payer (Medicare) billing profile in the dataset. Absence of Medicaid claims suggests limited participation or volume in state Medicaid programs and a payer mix concentrated on Medicare beneficiaries.

Despite very large absolute revenue from anti-VEGF therapy, the provider’s national competitive standing on the leading injection code is typical rather than dominant: J0178 ranks #370 of 3204 providers nationally (88th percentile; typical, unremarkable volume for this code) and J2777 ranks #531 of 2039 providers nationally (74th percentile; typical, unremarkable volume for this code). A similar pattern holds for the biosimilar Q5128 ($133.6K, 4.9% of Medicare revenue) which ranks #210 of 373 providers nationally (44th percentile; typical, unremarkable volume), indicating solid but not market-leading share among peers on injection therapies.

One notable operational outlier is diagnostic retinal imaging: 92134 shows 2.7K claims generating $71.8K (2.7% of Medicare revenue) and ranks #572 of 26868 providers nationally (98th percentile; extreme outlier, far above typical national volume for this code). This unusually high OCT imaging volume suggests an infrastructure and workflow optimized for high-throughput retinal imaging, likely supporting frequent monitoring and treatment decisions for injectable therapies.

Evaluation-and-management activity is meaningful and above typical national levels for established visits: 99213 has 560 claims ($33K, 1.2% of Medicare revenue) and ranks #22096 of 457151 providers nationally (95th percentile; notably above typical national volume for this code), while 99214 adds 268 claims ($23K, 0.9%). These E/M volumes are consistent with ongoing follow-up and chronic disease management required by frequent intravitreal injection protocols.

Procedural surgical volume is modest relative to injection and imaging work: 67042 (vitrectomy with ILM peeling) shows 17 claims for $14.5K (0.5% of Medicare revenue) and ranks #648 of 1087 providers nationally (36th percentile; typical, unremarkable volume). The data imply the practice performs some retina surgeries but that its primary revenue engine remains office-based injections and diagnostic services rather than high-volume surgical practice.

The provider’s NPI was enumerated on 2010-07-19 (~16 years ago), indicating an established tenure in the market that aligns with sustained, repeated-care services (high-volume injections and imaging) rather than a newly established operation. Tenure supports the interpretation that current billing patterns reflect a stable care model oriented to chronic retinal disease management.

Beyond the top injection and imaging codes, the presence of J3590 (unclassified biologics, 316 claims, $20.5K, 0.8% of Medicare revenue) and a spread of ophthalmic procedure and E/M codes shows some billing diversity but no substantial secondary revenue streams. Overall, revenue concentration in a few injection codes and very high OCT volume point to a specialized retina clinic focused on anti-VEGF and related retina services rather than a broad general ophthalmology practice.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,360	$690	$1.6M
J2777	Injection, faricimab‑svoa, 0.1 mg	19,980	$30	$579.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,840	$80	$150.8K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	570	$240	$133.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,660	$30	$71.8K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	560	$60	$33K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	270	$90	$23K
J3590	Unclassified biologics	320	$70	$20.5K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$850	$14.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	90	$110	$9.6K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Indiana Distribution

Mark Kaehr — 2 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Indiana

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	8	60	830	$690	$868.8K
J2777	9	40	6,750	$30	$395.6K
Q5128	4	10	570	$240	$175.2K
67028	13	80	550	$80	$78.6K
67042	8	20	20	$1,310	$47K
J3590	18	50	220	$60	$24.5K
92235	20	40	90	$100	$15.8K
99214	2,616	10,540	110	$80	$15.5K
67228	13	20	30	$230	$9.8K
99213	412	10,820	80	$50	$7.6K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mark Kaehr, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rodney Bucher	IN	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
Frederick Prall	IN	Retina Specialist (Ophthalmology) Physician	$3.3M	$0
Ramana Moorthy	IN	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Rita Singh-parikshak	IN	Ophthalmology Physician	$1.5M	$0
Gian Paolo Giuliari Gonzalez	OH	Ophthalmology Physician	$346.5K	$0

Nearby Providers

Other providers in the same ZIP code as Mark Kaehr, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Aspire Indiana Inc.	IN	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$26.2M
Landmark Recovery Of Carmel LLC	IN	Substance Abuse Rehabilitation Facility	$0	$26.2M
Little Star Center, Inc.	IN	Early Intervention Provider Agency	$0	$22.7M
Arrow Consultation Services, Inc.	IN	Developmentally Disabled Services Day Training Agency	$0	$10.5M
Indiana University Health North Hospital Inc	IN	General Acute Care Hospital	$0	$6.9M
Option Care Enterprises, Inc.	IN	Home Infusion Therapy Pharmacy	$0	$5.2M
Impact Physician Group, Indiana LLC	IN	Internal Medicine Physician	$0	$4.2M
Westmed, LLC	IN	Durable Medical Equipment & Medical Supplies	$0	$4M
Chinthala, PC	IN	Psychiatry Physician	$0	$3.9M
American Health Network Of Indiana, LLC	IN	Clinical Medical Laboratory	$2.2M	$1.6M

Mark Kaehr — Billing Profile & Reimbursement Data

Sign up for Mark Kaehr — Billing Profile & Reimbursement Data policy alerts

Mark Kaehr — Billing Profile & Reimbursement Data

Sign up for Mark Kaehr — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References